| Nivolumab/Ipilimumab in Second Line CUP-syndrome (NCT04131621) | University Hospital Heidelberg | 2019-12-12 |
| A Study of Modakafusp Alfa (TAK-573) Given by Itself and Together With Pembrolizumab in Adults With Advanced or Metastatic Solid Tumors (NCT04157517) | Teva Branded Pharmaceutical Products R&D LLC | 2019-12-12 |
| Topical Remetinostat Gel as Neoadjuvant Therapy in Patients With Squamous Cell Carcinoma (SCC) (NCT03875859) | Kavita Sarin | 2019-12-12 |
| A Clinical Trial Evaluating TG4050 in Head and Neck Cancer (NCT04183166) | Transgene | 2019-12-12 |
| 1911GCCC: Galeterone With Gemcitabine for Patients With Metastatic Pancreatic Adenocarcinoma (NCT04098081) | University of Maryland, Baltimore | 2019-12-12 |
| Study of TRIFLURIDINE/TIPIRACIL in Previously Treated Cholangiocarcinoma (NCT04076761) | Sunnybrook Health Sciences Centre | 2019-12-11 |
| Safety and Efficacy in Patients With Moderate to Severe Subacute and Chronic Atopic Dermatitis (NCT04137562) | EHL Bio Co., Ltd. | 2019-12-11 |
| L-DOS47 Plus Doxorubicin in Advanced Pancreatic Cancer (NCT04203641) | Helix BioPharma Corporation | 2019-12-11 |
| A Dose-range Finding Study of MAA868 in Patients With Atrial Fibrillation (NCT04213807) | Anthos Therapeutics, Inc. | 2019-12-11 |
| Treg Modulation With CD28 and IL-6 Receptor Antagonists (NCT04066114) | National Institute of Allergy and Infectious Diseases (NIAID) | 2019-12-11 |
| PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56 (NCT04199741) | Memorial Sloan Kettering Cancer Center | 2019-12-11 |
| Leflunomide in Treating Patients With High-Risk Smoldering Multiple Myeloma (NCT03952832) | City of Hope Medical Center | 2019-12-11 |
| A Phase 1/2 Study in Patients With HPV16+ Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma and Other Cancers (NCT04180215) | Hookipa Biotech GmbH | 2019-12-11 |
| Study of Induction PD-1 Blockade in Subjects With Locally Advanced Mismatch Repair Deficient Solid Tumors (NCT04165772) | Memorial Sloan Kettering Cancer Center | 2019-12-11 |
| A Phase 2 Study of ABBV-3067 Alone and in Combination With ABBV-2222 (NCT03969888) | AbbVie | 2019-12-11 |
| Safety and Immune Response of One Dose of OVX836 at Two Dose Levels, in Comparison to Influvac TetraTM, After Intramuscular Administration in Healthy Subjects Aged 18-65 Years (NCT04192500) | Osivax | 2019-12-11 |
| Clinical Study to Assess the Safety and Preliminary Efficacy of HCR040 in Acute Respiratory Distress Syndrome (NCT04289194) | Histocell, S.L. | 2019-12-10 |
| The Efficacy and Safety of Different Doses of SY-004 in Patients With Type 2 Diabetes Mellitus (NCT04217291) | Suzhou Yabao Pharmaceutical R&D Co., Ltd. | 2019-12-10 |
| Neuromuscular Blockade in Patients With Severe Renal Impairment (NCT03904550) | University of Texas Southwestern Medical Center | 2019-12-10 |
| Strategies for the Management of Atrial Fibrillation in patiEnts Receiving Dialysis (NCT03987711) | Unity Health Toronto | 2019-12-10 |
| Effect of Vitamin C in Autologous Stem Cell Transplantations (NCT03964688) | Maastricht University Medical Center | 2019-12-10 |
| Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist) (NCT04198766) | Inhibrx Biosciences, Inc | 2019-12-10 |
| Caries Prevention and Side Effects of Gum Arabic and Licorice Extracts Versus Chlorhexidine in High Caries Risk Patients (NCT03684993) | Cairo University | 2019-12-10 |
| COmbination of Radiotherapy With Anti-PD-1 Antibody for unREseCtable Biliary Tract Cancer (NCT03898895) | Sun Yat-sen University | 2019-12-10 |
| Safety and Efficacy of Therapeutic Hepatitis B Adenovirus Injection (T101) Combined With Nucleoside (Acid) Analogues in Chronic Hepatitis B Patients (NCT04189276) | Tasly Tianjin Biopharmaceutical Co., Ltd. | 2019-12-10 |
| Study Exploring the Effect of Crizanlizumab on Kidney Function in Patients With Chronic Kidney Disease Caused by Sickle Cell Disease (NCT04053764) | Novartis Pharmaceuticals | 2019-12-10 |
| A Clinical Trial Evaluating the Efficacy and Safety of HSK3486 Injectable Emulsion in Elective Surgery Patients (NCT04048811) | Sichuan Haisco Pharmaceutical Group Co., Ltd | 2019-12-09 |
| A Study to Evaluate the Efficacy and Safety of VIB4920 in Participants With Sjögren's Syndrome (NCT04129164) | Amgen | 2019-12-09 |
| A Study to Investigate OQL011 on VEGFR Inhibitor-Associated Hand-Foot Skin Reaction in Cancer Patients (NCT04088318) | OnQuality Pharmaceuticals (USA) LLC | 2019-12-09 |
| Transabdominal Plane (TAP) Blocks for Inguinal Hernia Repairs (NCT05672680) | Icahn School of Medicine at Mount Sinai | 2019-12-09 |
| Curcumin for Pediatric Nonalcoholic Fatty Liver Disease (NCT04109742) | Columbia University | 2019-12-09 |
| CHinese Acute Tissue-Based Imaging Selection for Lysis In Stroke -Tenecteplase (NCT04086147) | Huashan Hospital | 2019-12-09 |
| The Secret Trail of Moon (Serious Videogame) and Chess on ADHD: a Clinal Trial (NCT04355065) | Puerta de Hierro University Hospital | 2019-12-09 |
| Study of CX1106 in Patients With Advanced Head and Neck Squamous Cell Carcinoma (NCT04093115) | Beijing Konruns Pharmaceutical Co., Ltd. | 2019-12-09 |
| Venetoclax and Decitabine Assessment in Patients (≥60 - <75 Years) with Newly Diagnosed AML Eligible for Allo-SCT (NCT04476199) | Gruppo Italiano Trapianto di Midollo Osseo | 2019-12-09 |
| Study Assessed the Safety and Efficacy of Eltrombopag in Chinese Refractory or Relapsed Severe Aplastic Anemia (SAA) Subjects. (NCT03988608) | Novartis Pharmaceuticals | 2019-12-09 |
| Efficacy and Safety of MEDI3506 in Adult Subjects With Atopic Dermatitis (NCT04212169) | AstraZeneca | 2019-12-09 |
| A Study to Evaluate the Safety and Efficacy of VIB4920 in Participants With Rheumatoid Arthritis (NCT04163991) | Amgen | 2019-12-09 |
| Phase II Trial of Neoadjuvant and Adjuvant Anti-PD-1 Antibody Toripalimab Combined With CCRT in NPC Patients (NCT03925090) | Sun Yat-sen University | 2019-12-08 |
| Study of ZSP1273 in Patients With Acute Uncomplicated Influenza A (NCT04024137) | Guangdong Raynovent Biotech Co., Ltd | 2019-12-07 |
| Gilteritinib vs Midostaurin in FLT3 Mutated Acute Myeloid Leukemia (NCT03836209) | PrECOG, LLC. | 2019-12-06 |
| Pentaglobin in CRE and PA Neutropenic Infections (NCT03494959) | Gruppo Italiano Trapianto di Midollo Osseo | 2019-12-06 |
| CTx-1301 Comparative Bioavailability Study (NCT04138498) | Cingulate Therapeutics | 2019-12-06 |
| Reduced Intensity Flu/Mel/TBI Conditioning for HAPLO HCT Patients With Hematologic Malignancies (NCT04191187) | H. Lee Moffitt Cancer Center and Research Institute | 2019-12-06 |
| Efficacy and Safety of DaxibotulinumtoxinA (DAXI) for Injection for Treatment of Upper Facial Lines (NCT04259086) | Revance Therapeutics, Inc. | 2019-12-06 |
| A Phase 1/Phase 2 Study of Polyvalent Pneumococcal Conjugate Vaccine (V116) in Adults (V116-001) (NCT04168190) | Merck Sharp & Dohme LLC | 2019-12-06 |
| GLAD-AML - Glasdegib (Pf-04449913) With Two Standard Decitabine Regimens for Older Patients With Poor-risk Acute Myeloid Leukemia (NCT04051996) | Yale University | 2019-12-06 |
| Safety and Efficacy of IDA for Onchocerciasis (NCT04188301) | Washington University School of Medicine | 2019-12-06 |
| Phase II Clinical Trial of OCH-NCNP1 (NCT04211740) | National Center of Neurology and Psychiatry, Japan | 2019-12-06 |
| Immunotherapy for Recurrent Cervical Cancer Refractory to Platinum-based Chemotherapy (NCT04188860) | Lei Li | 2019-12-06 |
| Study of TPX-0046, A RET/SRC Inhibitor in Adult Subjects With Advanced Solid Tumors Harboring RET Fusions or Mutations (NCT04161391) | Turning Point Therapeutics, Inc. | 2019-12-06 |
| First-line Chemotherapy for Recurrent Cervical Cancer (NCT04188847) | Lei Li | 2019-12-06 |
| Effect of Roflumilast on Quality of Life, Lung Function and Mucus Properties in Patients With Bronchiectasis (NCT03988816) | University of Sao Paulo General Hospital | 2019-12-06 |
| Pancreatic Islet Transplantation Into the Anterior Chamber of the Eye (NCT02846571) | Midhat H. Abdulreda | 2019-12-05 |
| Palbociclib + Ganitumab In Ewing Sarcoma (NCT04129151) | Dana-Farber Cancer Institute | 2019-12-05 |
| Abscopal Effect of Radiotherapy and Nivolumab in Relapsed Hodgkin Lymphoma After Anti-PD1 Therapy (NCT03480334) | University of Cologne | 2019-12-05 |
| Clinical Safety and Scar Prevention Study of a Topical Antifibrotic Compound FS2. (NCT04186273) | University of British Columbia | 2019-12-05 |
| Measuring Blood Flow in the Brain After Epileptic Activity (NCT04028596) | Rijnstate Hospital | 2019-12-05 |
| A Study of LY3200882 and Pembrolizumab in Participants With Advanced Cancer (NCT04158700) | Eli Lilly and Company | 2019-12-05 |
| Tolerability and Efficacy of Midostaurin to 10-day Decitabine in Unfit Adult AML and High Risk MDS Patients (NCT04097470) | Stichting Hemato-Oncologie voor Volwassenen Nederland | 2019-12-05 |
| A Phase II Exploratory Clinical Trial of Multiple Drug Combinations in the Treatment of Advanced Esophageal Squamous Cell Carcinoma (NCT03736863) | The First Affiliated Hospital of Zhengzhou University | 2019-12-05 |
| Real-time Ultrasound Imaging as Feedback for Deep Cervical Extensors Activation (NCT04201483) | University of Valencia | 2019-12-05 |
| A Study to Evaluate the Effectiveness and Safety of IONIS-FB-LRx, an Antisense Inhibitor of Complement Factor B, in Adult Participants With Primary IgA Nephropathy (NCT04014335) | Ionis Pharmaceuticals, Inc. | 2019-12-04 |
| Mechanisms of Lorcaserin for Smoking Cessation (NCT04396834) | The Mind Research Network | 2019-12-04 |
| A Study to Evaluate the Efficacy and Safety of ALS-L1023 in Subjects With NASH (NCT04342793) | AngioLab, Inc. | 2019-12-04 |
| Prostate Specific Membrane Antigen (PMSA)-Based PET Imaging of High Risk Prostate Cancer (NCT03976843) | National Cancer Institute (NCI) | 2019-12-04 |
| Safety and Efficacy of ARQ-154 Foam in Subjects With Seborrheic Dermatitis (NCT04091646) | Arcutis Biotherapeutics, Inc. | 2019-12-04 |
| PHP and Immunotherapy in Metastasized UM (NCT04283890) | Leiden University Medical Center | 2019-12-04 |
| Study Evaluating the Safety, Efficacy and Pharmacokinetics of CA-008 (Vocacapsaicin) (NCT04203537) | Concentric Analgesics | 2019-12-04 |
| Descartes-08 CAR-T Cells in Generalized Myasthenia Gravis (MG) (NCT04146051) | Cartesian Therapeutics | 2019-12-04 |
| A Study to Assess the Safety, Efficacy, and Pharmacokinetics of Miricorilant (CORT118335) in Obese Adults With Schizophrenia or Bipolar Disorder Treated With Antipsychotic Medications (NCT03818256) | Corcept Therapeutics | 2019-12-04 |
| Testing the Addition of an Immunotherapy Drug, Tremelimumab, to the PARP Inhibition Drug, Olaparib, for Recurrent Ovarian, Fallopian Tube or Peritoneal Cancer (NCT04034927) | National Cancer Institute (NCI) | 2019-12-04 |
| Effects of Gum Arabic on Metabolic Syndrome Parameters in Postmenopausal Women (NCT04978103) | University of Khartoum | 2019-12-04 |
| Preventing Childhood HIV: Rescue Intervention. ANRS 12388 PREVENIR-PEV (NCT03869944) | ANRS, Emerging Infectious Diseases | 2019-12-04 |
| Adoptive Transfer of Tumor Infiltrating Lymphocytes for Advanced Solid Cancers (NCT03935893) | Udai Kammula | 2019-12-03 |
| AVB-S6-500 and Durvalumab in Treating Patients With Platinum-Resistant or Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (NCT04019288) | M.D. Anderson Cancer Center | 2019-12-03 |
| Hydroxychloroquine to Increase Tumor Suppressor PAR-4 Levels in Oligometastatic Prostate Cancer (NCT04011410) | Patrick Hensley | 2019-12-03 |
| Study of Crizotinib for ROS1 and MET Activated Lung Cancer (NCT04084717) | University Health Network, Toronto | 2019-12-03 |
| A Vehicle Controlled Study to Evaluate Safety and Efficacy of Topical TMB-001 for Treatment of Congenital Ichthyosis (NCT04154293) | LEO Pharma | 2019-12-03 |
| Glasdegib for Chronic Graft-Versus-Host Disease (NCT04111497) | Fred Hutchinson Cancer Center | 2019-12-03 |
| Phase II Study of Herzuma® Plus Gedatolisib in Patients With HER-2 Positive Metastatic Breast Cancer (NCT03698383) | Korean Cancer Study Group | 2019-12-03 |
| Study of AMG531 (Romiplostim) in Patients With Aplastic Anemia (NCT04095936) | Kyowa Kirin Co., Ltd. | 2019-12-03 |
| A Safety and Efficacy Study of SHR4640 and Febuxostat in Subjects With Hyperuricemia (NCT04180982) | Jiangsu HengRui Medicine Co., Ltd. | 2019-12-03 |
| Allogeneic NK Cell ("SMT-NK") in Combination With Pembrolizumab in Advanced Biliary Tract Cancer (NCT03937895) | SMT bio Co., Ltd. | 2019-12-03 |
| FOLFOXIRI Plus Panitumumab in Metastatic RAS Wild-type, Left-sided Colorectal Cancer (NCT04169347) | Criterium, Inc. | 2019-12-02 |
| Open-label Study of VTS-270 in Participants With Neurologic Manifestations of Niemann-Pick Type C1 (NCT03879655) | Mandos LLC | 2019-12-02 |
| A Study to Assess Efficay and Safety of LC350189 Different Doses in Gout Patients With Hyperuricemia (NCT03934099) | LG Chem | 2019-12-02 |
| Steroid Dosing by bioMARker Guided Titration in Critically Ill Patients With Pneumonia (NCT03852537) | Mayo Clinic | 2019-12-02 |
| A Study to Evaluate the Safety and Efficacy of PF-06650833, PF-06700841, and PF 06826647 in Adults With Hidradenitis Suppurativa (NCT04092452) | Pfizer | 2019-12-02 |
| Metabolic Cofactor Supplementation in Alzheimer's Disease (AD) and Parkinson's Disease (PD) Patients (NCT04044131) | Istanbul Medipol University Hospital | 2019-12-02 |
| A Study to Evaluate the Safety and the Efficacy of EscharEx (EX-02 Formulation) in Debridement of Venous Leg Ulcers (NCT03588130) | MediWound Ltd | 2019-12-02 |
| Exploratory Study of NS-089/NCNP-02 in DMD (NCT04129294) | National Center of Neurology and Psychiatry, Japan | 2019-12-02 |
| Study of CVN424 in Parkinson's Disease Patients With Motor Fluctuations (NCT04191577) | Cerevance Beta, Inc. | 2019-12-02 |
| A Phase II Study of RBM-007 Alone and RBM-007 With Eylea® in Subjects With Wet Age-related Macular Degeneration (NCT04200248) | Ribomic USA Inc | 2019-12-02 |
| Cabergoline for the Treatment of Chronic Pain Due to Endometriosis (NCT03928288) | Boston Children's Hospital | 2019-12-02 |
| Enasidenib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia With an IDH2 Gene Mutation (NCT03881735) | Roswell Park Cancer Institute | 2019-12-02 |
| Study of Ponatinib (Iclusig) for Prevention of Relapse After Allogeneic Stem Cell Transplantation (allo-SCT) in FLT3-ITD AML Patients (NCT03690115) | Versailles Hospital | 2019-12-02 |
| Safety and Tolerability of Perampanel in Amyotrophic Lateral Sclerosis Patients (NCT03377309) | American University of Beirut Medical Center | 2019-12-01 |
| Safety and Efficacy Study of Chemotherapy Plus Apatinib as Second-line Therapy in Metastatic Colorectal Cancer (NCT03193814) | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2019-12-01 |
| Predictive Factors for Recovery in Idiopathic Sensory Neural Hearing Loss (NCT05112354) | Assiut University | 2019-12-01 |